368 related articles for article (PubMed ID: 8103763)
1. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
3. Morning versus evening dose: a comparison of three H2-receptor blockers in duodenal ulcer healing.
Khasawneh SM; Affarah HB
Am J Gastroenterol; 1992 Sep; 87(9):1180-2. PubMed ID: 1519576
[TBL] [Abstract][Full Text] [Related]
4. Effect of oral H2-receptor antagonists on left ventricular systolic function and exercise capacity in patients with chronic stable heart failure.
Lucas BD; Williams MA; Mohiuddin SM; LaMadrid LJ; Schroeder LJ; Hilleman DE
Pharmacotherapy; 1998; 18(4):824-30. PubMed ID: 9692655
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment H2 receptor antagonists that differ in P450 modulation activity: comparative effects on paclitaxel clearance rates and neutropenia.
Slichenmyer WJ; Donehower RC; Chen TL; Bowling MK; McGuire WP; Rowinsky EK
Cancer Chemother Pharmacol; 1995; 36(3):227-32. PubMed ID: 7781143
[TBL] [Abstract][Full Text] [Related]
6. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
[TBL] [Abstract][Full Text] [Related]
7. Effect of the H2 histamine receptor antagonist on oxygen metabolism in some morphotic blood elements in patients with ulcer disease.
Kedziora-Kornatowska K; Tkaczewski W; Blaszczyk J; Buczynski A; Chojnacki J; Kedziora J
Hepatogastroenterology; 1998; 45(19):276-80. PubMed ID: 9496526
[TBL] [Abstract][Full Text] [Related]
8. Implementing therapeutic interchange of intravenous famotidine for cimetidine and ranitidine.
Oh T; Franko TG
Am J Hosp Pharm; 1990 Jul; 47(7):1547-51. PubMed ID: 2114789
[TBL] [Abstract][Full Text] [Related]
9. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.
Howard JM; Chremos AN; Collen MJ; McArthur KE; Cherner JA; Maton PN; Ciarleglio CA; Cornelius MJ; Gardner JD; Jensen RT
Gastroenterology; 1985 Apr; 88(4):1026-33. PubMed ID: 2857672
[TBL] [Abstract][Full Text] [Related]
10. Effects of prolonged oral cimetidine, ranitidine, and famotidine therapy on antipyrine elimination.
Sakaue H; Akamatsu K; Hirabayashi Y; Sasaki T; Nakanishi K; Okada S; Kanaoka M; Nishinobu M; Masumoto S; Ohta Y
Clin Ther; 1987; 9(6):602-6. PubMed ID: 2894244
[TBL] [Abstract][Full Text] [Related]
11. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
12. Comparison of famotidine with cimetidine and ranitidine.
Berardi RR; Tankanow RM; Nostrant TT
Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of oral famotidine and ranitidine on gastric volume and pH.
Dubin SA; Silverstein PI; Wakefield ML; Jense HG
Anesth Analg; 1989 Nov; 69(5):680-3. PubMed ID: 2572186
[No Abstract] [Full Text] [Related]
14. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
De Natale G; De Natale F; Marino A
Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647
[TBL] [Abstract][Full Text] [Related]
15. The clinical use of histamine-2 receptor antagonists.
Michocki RJ; Richardson JP
Md Med J; 1992 May; 41(5):397-400. PubMed ID: 1625532
[TBL] [Abstract][Full Text] [Related]
16. [Comparative studies on hemodynamic effects of intravenous cimetidine, ranitidine and famotidine in intensive care unit patients].
Omote K; Namiki A; Sumita S; Takahashi T; Ujike Y; Hagiwara T
Masui; 1987 Jun; 36(6):940-7. PubMed ID: 2888909
[No Abstract] [Full Text] [Related]
17. [Strong inhibition of gastric acid secretion: when is it justifiable?].
Dobrilla G; Amplaz S; Benvenuti S; Bertozzo A
G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653
[No Abstract] [Full Text] [Related]
18. Comparative evaluation of the hemodynamic effects of oral cimetidine, ranitidine, and famotidine as determined by echocardiography.
Welage LS; Dunn-Kucharski VA; Berardi RR; Shea MJ; Dechert RE; Bleske BE
Pharmacotherapy; 1995; 15(2):158-63. PubMed ID: 7624262
[TBL] [Abstract][Full Text] [Related]
19. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
Festen HP; Schenk E; Tan G; Snel P; Nelis F
Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
[TBL] [Abstract][Full Text] [Related]
20. [Comparison between ranitidine, famotidine, and omeprazole in the treatment of bleeding duodenal ulcer].
Maculotti L; Pradella P
Minerva Chir; 1995 Mar; 50(3):279-81. PubMed ID: 7659265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]